Back to CONGRESS ASSET MANAGEMENT CO CONGRESS ASSET MANAGEMENT CO

NBIXNBIX
Showing 7 of 22 quarters

Position history for CONGRESS ASSET MANAGEMENT COCONGRESS ASSET MANAGEMENT CO's holdings in NEUROCRINE BIOSCIENCES INC

Yes. Congress Asset Management holds 120,842 shares of NBIX (Neurocrine Biosciences), worth $17.1M, as of its Q3 2026 13F filing. It increased the position by 38,356 shares (+46.5%) from Q2 2026. Congress Asset Management has held NBIX since Q2 2026, across 2 quarterly 13F filings. NBIX is 0.1% of Congress Asset Management's reported 13F portfolio.

Current Value

$17.1M

Current Shares

120,842

Total Value Change

+$17.1M

Total Shares Change

+120,842

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
120,842
+46.5%
$17.1M0.1%$141.84
46
2026-Q2
New
82,486
-
$13.9M0.1%$168.54
39
2025-Q4
Exited
0
-100.0%
$00.0%$141.83
0
2025-Q3
New
2,690
-
$377,6220.0%$140.38
33
2025-Q2
Exited
0
-100.0%
$00.0%$125.69
0
2025-Q1
New
2,363
-
$261,3480.0%$110.60
32
2024-Q3
Exited
0
-100.0%
$00.0%$115.22
0

Other major holders of NBIX: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used